Digest Network Come funziona
Network
/
Società
Si
Non verificato

Sirius Therapeutics

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

3 comunicati stampa

Guarda tutti i comunicati
09/05/2025
Salute
Medicina - Varie
Sanità
Farmaceutica
Cardiologia
Biotecnologia
Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases
Fonte
Sirius Therapeutics
Emittente
Business Wire
1.00
0
10/12/2024
Fiere
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Cardiologia
Biotecnologia
Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
Fonte
Sirius Therapeutics
Emittente
Business Wire
1.00
0
03/12/2024
Eventi
Industria
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition
Fonte
Sirius Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0